Syndax Pharmaceuticals Inc (SNDX) Reports Material Event to SEC
Filing Details Syndax Pharmaceuticals Inc (NASDAQ:SNDX) filed a Form 8-K with the Securities and Exchange Commission on July 14, 2026, disclosing a material event. Market Context…
Read more
